YOUR HEALTH: VHL, new drug for genetic disease shrinks tumors
VHL puts people at higher risk of cancerous and benign tumors in multiple organs.
Source: wafb.com
/cloudfront-us-east-1.images.arcpublishing.com/gray/LZ3FJH25OZDUZADL2STK4RULZQ.jpg)
Othon Iliopoulos News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Othon Iliopoulos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Othon Iliopoulos Today - Breaking & Trending Today
Treating Von Hippel-Lindau disease by shrinking tumors
VHL is a genetic disease that puts people at higher risk of cancerous and benign tumors in multiple organs. Now, a new drug is stopping those tumors from growing.
Source: wqad.com
Welireg, a new drug to fight cancer, could offer hope for many
To quote Kramer, “this is a game changer for a lot of people.”
Source: firstcoastnews.com
2021 Research Grant Recipients Announced by the VHL Alliance
2021 Research Grant Recipients Announced by the VHL Alliance Global Research Program Supports Curing Cancer through VHL News provided by Share this article Share this article BOSTON, Jan. 19, 2021 /PRNewswire/ -- The VHL Alliance (VHLA) today announced the 2021 recipients of the VHLA Competitive Research Grant Program. This year, three grantees were chosen. Scientists are increasingly aware that curing von Hippel-Lindau disease, a genetic form of cancer – is a key step to curing cancer, leading to a significant increase in the quality of research grant applicants in the program year afte...
Source: prnewswire.com